EUVIMEDOpdag EUVIMED
Open access

Differential discounting of past and future gains and losses in individuals in recovery from substance use disorder.

Rafaela M Fontes iD, Ana Carolina L Bovo, Roberta Freitas-Lemos, Warren K Bickel iD

Experimental and Clinical Psychopharmacology · 2025-06 · 33 (3) · 291-299

DOI: 10.1037/pha0000769 ↗

At a glance

Journal article in Experimental and Clinical Psychopharmacology, 2025-06. Written by Rafaela M Fontes and 3 co-authors. Institution: Fralin Biomedical Research Institute, Virginia Tech Carilion. Major MEDLINE topics: Substance-Related Disorders, Delay Discounting. Cited 5 times so far (Crossref). The full text is freely available in PubMed Central. Funded by: Virginia Tech Carilion; Fralin Biomedical Research Institute, NCI NIH HHS, National Institutes of Health; National Institute on Drug Abuse.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Individuals with substance use disorder (SUD) show consistently higher delay discounting (DD) rates than controls for both future and past outcomes, as well as for gains and losses. However, differences in these DD effects (e.g., tense and sign) among individuals in SUD recovery have yet to be explored. Therefore, the goal of the present study was to (a) investigate differences in discounting of past and future gains and losses among individuals in SUD recovery and (b) examine differences in these DD effects between individuals in different stages of remission (i.e., not in remission, in early remission, or in sustained remission). Our results indicate that individuals in recovery discount past and future gains, but not losses, symmetrically. Additionally, individuals in recovery discount gains more than losses (i.e., sign effect) for the future but not for the past. Finally, those in sustained remission showed significantly lower DD rates than those not in remission, regardless of the DD task. Thus, other discounting tasks might provide a similarly accurate measure of DD and can be employed to assess differences in discounting between those in remission and those not in remission. (PsycInfo Database Record (c) 2025 APA, all rights reserved).

Subjects

MeSH terms (MEDLINE)

Substance-Related DisordersDelay DiscountingHumansMaleFemaleAdultYoung AdultMiddle AgedReward

Authors and institutions

  • Fralin Biomedical Research Institute, Virginia Tech Carilion.

ORCID profiles: Rafaela M Fontes, Warren K Bickel

Funding

  • Virginia Tech Carilion; Fralin Biomedical Research Institute
  • NCI NIH HHS
  • National Institutes of Health; National Institute on Drug Abuse
  • NIDA NIH HHS
  • National Institutes of Health; National Institute on Alcohol Abuse and Alcoholism
  • NIAAA NIH HHS
  • National Institutes of Health
  • Virginia Tech Carilion

Cite

APA

Fontes, R. M., Bovo, A. C. L., Freitas-Lemos, R., & Bickel, W. K. (2025). Differential discounting of past and future gains and losses in individuals in recovery from substance use disorder. Experimental and Clinical Psychopharmacology, 33(3), 291-299. https://doi.org/10.1037/pha0000769

Vancouver

Fontes RM, Bovo ACL, Freitas-Lemos R, Bickel WK. Differential discounting of past and future gains and losses in individuals in recovery from substance use disorder. Experimental and Clinical Psychopharmacology. 2025;33(3):291-299. doi:10.1037/pha0000769

BibTeX
@article{Fontes2025,
  author = {Fontes, Rafaela M and Bovo, Ana Carolina L and Freitas-Lemos, Roberta and Bickel, Warren K},
  title = {Differential discounting of past and future gains and losses in individuals in recovery from substance use disorder},
  journal = {Experimental and Clinical Psychopharmacology},
  year = {2025},
  volume = {33},
  number = {3},
  pages = {291--299},
  doi = {10.1037/pha0000769}
}
Start for free →